Sun Yong Jeong
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$8.0MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $8.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 26, 2023 | NIH | SBIR Phase II Preventing Neurovascular Matrix Degradation and Hemorrhage in Acute Ischemic Stroke | $1.3M | TRANSLATIONAL SCIENCES INC. |
| Aug 12, 2022 | NIH | SBIR Phase II Preventing Neurovascular Matrix Degradation and Hemorrhage in Acute Ischemic Stroke | $1.2M | TRANSLATIONAL SCIENCES INC. |
| Apr 13, 2022 | NIH | SBIR Phase II Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial | $1.4M | TRANSLATIONAL SCIENCES INC. |
| Jul 2, 2021 | NIH | SBIR Phase II Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial | $1.4M | TRANSLATIONAL SCIENCES INC. |
| Aug 13, 2020 | NIH | SBIR Phase II HLS Potent, novel inhibitor of fibrinolytic hemorrhage- Phase II | $1.1M | TRANSLATIONAL SCIENCES INC. |
| Sep 24, 2019 | NIH | STTR Phase I Preventing Neurovascular Matrix Degradation and Hemorrhage in Acute Ischemic Stroke | $336K | TRANSLATIONAL SCIENCES INC. |
| Aug 11, 2019 | NIH | SBIR Phase II HLS Potent, novel inhibitor of fibrinolytic hemorrhage- Phase II | $1.3M | TRANSLATIONAL SCIENCES INC. |
Peer ranks
Federal funding#111
Awards as PI#250
Patents#273
Companies
- TRANSLATIONAL SCIENCES INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.